3.64 USD
+0.77 (+26.83%)
PETS gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 122 industry peers in the Specialty Retail industry. The financial health of PETS is average, but there are quite some concerns on its profitability. PETS is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year PETS has reported negative net income.
PETS had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: PETS reported negative net income in multiple years.
Each year in the past 5 years PETS had a positive operating cash flow.
1.2 Ratios
The Return On Assets of PETS (-4.22%) is worse than 68.85% of its industry peers.
PETS has a Return On Equity (-7.37%) which is in line with its industry peers.
PETS has a Return On Invested Capital of 0.49%. This is in the lower half of the industry: PETS underperforms 61.48% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.22% | ||
| ROE | -7.37% | ||
| ROIC | 0.49% |
ROA(3y)-2.83%
ROA(5y)3.96%
ROE(3y)-4.97%
ROE(5y)4.31%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
PETS has a worse Operating Margin (0.24%) than 61.48% of its industry peers.
PETS's Gross Margin of 30.46% is on the low side compared to the rest of the industry. PETS is outperformed by 65.57% of its industry peers.
In the last couple of years the Gross Margin of PETS has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.24% | ||
| PM (TTM) | N/A | ||
| GM | 30.46% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.16%
GM growth 5Y1.28%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PETS is destroying value.
The number of shares outstanding for PETS has been reduced compared to 1 year ago.
The number of shares outstanding for PETS has been increased compared to 5 years ago.
There is no outstanding debt for PETS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 2.86 indicates that PETS is not a great score, but indicates only limited risk for bankruptcy at the moment.
PETS's Altman-Z score of 2.86 is fine compared to the rest of the industry. PETS outperforms 67.21% of its industry peers.
PETS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.86 |
ROIC/WACC0.05
WACC9.65%
2.3 Liquidity
PETS has a Current Ratio of 1.26. This is a normal value and indicates that PETS is financially healthy and should not expect problems in meeting its short term obligations.
PETS's Current ratio of 1.26 is in line compared to the rest of the industry. PETS outperforms 45.90% of its industry peers.
PETS has a Quick Ratio of 1.26. This is a bad value and indicates that PETS is not financially healthy enough and could expect problems in meeting its short term obligations.
PETS has a Quick ratio of 1.00. This is in the better half of the industry: PETS outperforms 73.77% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
PETS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.00%, which is quite impressive.
Looking at the last year, PETS shows a very negative growth in Revenue. The Revenue has decreased by -19.24% in the last year.
PETS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.39% yearly.
EPS 1Y (TTM)22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-125.68%
Revenue 1Y (TTM)-19.24%
Revenue growth 3Y-6.02%
Revenue growth 5Y-4.39%
Sales Q2Q%-30.13%
3.2 Future
Based on estimates for the next years, PETS will show a very strong growth in Earnings Per Share. The EPS will grow by 27.38% on average per year.
The Revenue is expected to decrease by -3.12% on average over the next years.
EPS Next Y26.23%
EPS Next 2Y42.6%
EPS Next 3Y27.38%
EPS Next 5YN/A
Revenue Next Year-14.05%
Revenue Next 2Y-5.92%
Revenue Next 3Y-3.12%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for PETS. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PETS. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
99.18% of the companies in the same industry are more expensive than PETS, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 0.74 |
4.3 Compensation for Growth
PETS's earnings are expected to grow with 27.38% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.6%
EPS Next 3Y27.38%
5. Dividend
5.1 Amount
PETS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:PETS (12/16/2025, 12:22:09 PM)
3.64
+0.77 (+26.83%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners35.99%
Inst Owner Change-3.37%
Ins Owners5.22%
Ins Owner Change6.26%
Market Cap76.51M
Revenue(TTM)226.97M
Net Income(TTM)-6.27M
Analysts40
Price Target2.81 (-22.8%)
Short Float %11.18%
Short Ratio0.56
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend0.01
Dividend Growth(5Y)-61.77%
DP-2.89%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-808.7%
Min EPS beat(2)-1129.17%
Max EPS beat(2)-488.23%
EPS beat(4)2
Avg EPS beat(4)-256.31%
Min EPS beat(4)-1129.17%
Max EPS beat(4)296.08%
EPS beat(8)3
Avg EPS beat(8)-276.16%
EPS beat(12)3
Avg EPS beat(12)-223.62%
EPS beat(16)4
Avg EPS beat(16)-171.34%
Revenue beat(2)0
Avg Revenue beat(2)-14.24%
Min Revenue beat(2)-15.64%
Max Revenue beat(2)-12.84%
Revenue beat(4)0
Avg Revenue beat(4)-12.79%
Min Revenue beat(4)-15.64%
Max Revenue beat(4)-11.17%
Revenue beat(8)1
Avg Revenue beat(8)-8.02%
Revenue beat(12)1
Avg Revenue beat(12)-7.7%
Revenue beat(16)1
Avg Revenue beat(16)-7.62%
PT rev (1m)0%
PT rev (3m)-8.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-16.67%
EPS NY rev (1m)0%
EPS NY rev (3m)-83.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.94%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.34 | ||
| P/FCF | N/A | ||
| P/OCF | 16.22 | ||
| P/B | 0.9 | ||
| P/tB | 1.7 | ||
| EV/EBITDA | 0.74 |
EPS(TTM)-0.3
EYN/A
EPS(NY)-0.22
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)0.22
OCFY6.17%
SpS10.8
BVpS4.05
TBVpS2.15
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.22% | ||
| ROE | -7.37% | ||
| ROCE | 0.63% | ||
| ROIC | 0.49% | ||
| ROICexc | 1.36% | ||
| ROICexgc | N/A | ||
| OM | 0.24% | ||
| PM (TTM) | N/A | ||
| GM | 30.46% | ||
| FCFM | N/A |
ROA(3y)-2.83%
ROA(5y)3.96%
ROE(3y)-4.97%
ROE(5y)4.31%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.16%
GM growth 5Y1.28%
F-Score5
Asset Turnover1.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 72.64% | ||
| Cap/Sales | 2.25% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 62.27% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 2.86 |
F-Score5
WACC9.65%
ROIC/WACC0.05
Cap/Depr(3y)94.91%
Cap/Depr(5y)89.72%
Cap/Sales(3y)1.98%
Cap/Sales(5y)1.47%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-125.68%
EPS Next Y26.23%
EPS Next 2Y42.6%
EPS Next 3Y27.38%
EPS Next 5YN/A
Revenue 1Y (TTM)-19.24%
Revenue growth 3Y-6.02%
Revenue growth 5Y-4.39%
Sales Q2Q%-30.13%
Revenue Next Year-14.05%
Revenue Next 2Y-5.92%
Revenue Next 3Y-3.12%
Revenue Next 5YN/A
EBIT growth 1Y105.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year55.61%
EBIT Next 3Y48.58%
EBIT Next 5YN/A
FCF growth 1Y-103.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y9.29%
OCF growth 3Y-36.58%
OCF growth 5Y-34.4%
PETMED EXPRESS INC / PETS FAQ
What is the ChartMill fundamental rating of PETMED EXPRESS INC (PETS) stock?
ChartMill assigns a fundamental rating of 3 / 10 to PETS.
What is the valuation status of PETMED EXPRESS INC (PETS) stock?
ChartMill assigns a valuation rating of 1 / 10 to PETMED EXPRESS INC (PETS). This can be considered as Overvalued.
What is the profitability of PETS stock?
PETMED EXPRESS INC (PETS) has a profitability rating of 2 / 10.
How financially healthy is PETMED EXPRESS INC?
The financial health rating of PETMED EXPRESS INC (PETS) is 6 / 10.
Can you provide the dividend sustainability for PETS stock?
The dividend rating of PETMED EXPRESS INC (PETS) is 0 / 10 and the dividend payout ratio is -2.89%.